Risk factors for recurrence of borderline ovarian tumours: A tertiary centre experience

被引：4

作者：

Demirkiran, Fuat ^{[1
]}

Sal, Veysel ^{[1
]}

Bese, Tugan ^{[1
]}

Tokgozoglu, Nedim ^{[1
]}

Erenel, Hakan ^{[2
]}

Sofiyeva, Nigar ^{[1
]}

Kahramanoglu, Ilker ^{[1
]}

Arvas, Macit ^{[1
]}

机构：

[1] Istanbul Univ, Cerrahpasa Fac Med, Div Gynecol Oncol, Dept Obstet & Gynecol, Istanbul, Turkey

[2] Sisli Hamidiye Etfal Training & Res Hosp, Dept Obstet & Gynecol, Istanbul, Turkey

来源：

JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2016年 / 36卷 / 08期

关键词：

Borderline; ovarian; prognostic factors; recurrence; surgery; SURVIVAL; PATTERNS; IMPLANTS; OUTCOMES; WOMEN;

D O I：

10.1080/01443615.2016.1188276

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The aim of this study was to evaluate the risk factors for recurrence of borderline ovarian tumours. This study investigated 127 women who were finally diagnosed with borderline epithelial ovarian tumours. Most of them were diagnosed in stage I (83.4%). With a median follow-up of 81.8 months (range: 14-205), the median time to recurrence was 22.4 months (range: 3-74). Five-year recurrence-free survival (RFS) and overall survival (OS) rates were 85.8% and 97.6%, respectively. In multivariate analysis, invasive implants and fertility-sparing surgery were found to be independent prognostic factors for 5-year RFS. Overall, 20 patients (15.7%) experienced relapse within the observation period. Although there is no consensus about high-risk category of borderline ovarian tumours, invasive implants and conservative surgery were closely related to the recurrence. Patients presenting these risk factors should undergo closer follow-up.

引用

页码：1036 / 1040

页数：5

共 50 条

[31] Borderline ovarian tumours
Ilin, Anton
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : 7 - 7
[32] Borderline ovarian tumours
Ilin, Anton
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : 9 - 9
[33] Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiological Aspects and Risk Factors
Ouldamer, L.
Body, G.
Darai, E.
Bendifallah, S.
GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2020, 48 (03): : 239 - 247
[34] Behavior of borderline ovarian tumours (BOTs): Single institution experience
Oaknin, A. M.
Romeo, M.
Pons, F.
Perez, X.
Barretina, P.
Vidal, A.
Marti, L.
Barahona, M.
Germa, J.
Ponce, J.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[35] Prognostic factors predicting recurrence in borderline ovarian tumors
Wu, Tzu-I
Lee, Chyi-Long
Wu, Meng-Yu
Hsueh, Swei
Huang, Kuan-Gen
Yeh, Chi-Ju
Lai, Chyong-Huey
GYNECOLOGIC ONCOLOGY, 2009, 114 (02) : 237 - 241
[36] Malignant mixed ovarian germ cell tumours: a 9 years' experience from a tertiary referral centre
Arora, I.
Sarwar, N.
Seckl, M.
Kaur, B.
VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S30 - S30
[37] EVALUATION OF FACTORS PREDICTING RECURRENCE IN BORDERLINE OVARIAN TUMORS
Jain, V.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A646 - A646
[38] EVALUATION OF RISK FACTORS ASSOCIATED WITH RELAPSE AND RECURRENCE OF BORDERLINE OVARIAN TUMORS WITH NO INVASIVE IMPLANT
Tounsi, N.
Bouzaiene, H.
Chemlali, M.
Abdelwahed, N.
Doghri, R.
Hantouse, H.
Bouazize, H.
Hechiche, M.
Ben Hassouna, J.
Rahel, K.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1608 - 1608
[39] Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence
Morice, Philippe
Uzan, Catherine
Fauvet, Raffaele
Gouy, Sebastien
Duvillard, Pierre
Darai, Emile
LANCET ONCOLOGY, 2012, 13 (03): : E103 - E115
[40] EXPLORING THE IMPACT OF SURGICAL INTERVENTIONS AND IDENTIFYING RISK FACTORS FOR RECURRENCE IN BORDERLINE OVARIAN TUMORS
Lee, Seon Mi
Lee, Sanghoon
Song, Jae Yun
Seol, Aeran
Cho, Hyun Woong
Min, Kyung Jin
Hong, Jin Hwa
Lee, Jae Kwan
Lee, Nak Woo
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A188 - A189

← 1 2 3 4 5 →